There's always going to be set backs with a company like this, that's why it's important to have a diverse pipeline.
The company is focusing on selling the product that works that there is currently demand for - better than tripling down on the failures. Why not focus on increasing revenue, then pump that back into R+D?
- Forums
- ASX - By Stock
- PNV
- Getting disillusioned
Getting disillusioned, page-79
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.00 |
Change
-0.045(2.21%) |
Mkt cap ! $1.388B |
Open | High | Low | Value | Volume |
$2.02 | $2.04 | $1.99 | $1.664M | 828.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 579 | $2.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.00 | 6078 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1390 | 2.000 |
12 | 11604 | 1.995 |
15 | 20047 | 1.990 |
12 | 20863 | 1.985 |
9 | 61035 | 1.980 |
Price($) | Vol. | No. |
---|---|---|
2.010 | 26705 | 23 |
2.020 | 40201 | 18 |
2.030 | 52713 | 13 |
2.040 | 31312 | 9 |
2.050 | 153308 | 7 |
Last trade - 15.28pm 18/11/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online